N2-[(benzyloxy)carbonyl)-N1-[(3S)-2-oxotetrahydrofuran-3-yl]-L-leucinamide | 167766-55-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N2-[(benzyloxy)carbonyl)-N1-[(3S)-2-oxotetrahydrofuran-3-yl]-L-leucinamide
• 英文别名: N2-[(benzyloxy)carbonyl]-N'-[(3S)-2-oxotetrahydrofuran-3-yl]-L-leucinamide；N2-[(benzyloxy)carbonyl]-N1-[(3S)-2-oxotetrahydrofuran-3-yl]-L-leucinamide；(S)-3-[[N-benzyloxycarbonyl-(L)-leucyl]amino]tetrahydrofuran-2-one；benzyl N-[(2S)-4-methyl-1-oxo-1-[[(3S)-2-oxooxolan-3-yl]amino]pentan-2-yl]carbamate
• CAS: 167766-55-4
• 化学式: C₁₈H₂₄N₂O₅
• 分子量: 348.399
• InChiKey: XCHLXSHJGWOUAO-GJZGRUSLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  25
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  93.7
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  N2-[(benzyloxy)carbonyl)-N1-[(3S)-2-oxotetrahydrofuran-3-yl]-L-leucinamide 在 二异丁基氢化铝 作用下， 以 二氯甲烷 为溶剂， 反应 0.25h， 以72%的产率得到(3S)-3-((S)-2-benzyloxycarbonylamino-4-methylvalerylamino)-2-tetrahydrofuranol
  参考文献：
  名称：

  AMIDINE DERIVATIVES AND THEIR APPLICATIONS AS A MEDICAMENT

  摘要：

  这项发明涉及一般式（I）的胍衍生物，其具有钙蛋白酶的抑制活性和/或氧化反应活性的捕捉活性。

  公开号：

  US20090018120A1
• 作为产物：
  描述：

  N-苄氧羰基-L-亮氨酸 、 高丝氨酸内酯氢溴酸盐 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 15.0h， 以68%的产率得到N2-[(benzyloxy)carbonyl)-N1-[(3S)-2-oxotetrahydrofuran-3-yl]-L-leucinamide
  参考文献：
  名称：

  AMIDINE DERIVATIVES AND THEIR APPLICATIONS AS A MEDICAMENT

  摘要：

  这项发明涉及一般式（I）的胍衍生物，其具有钙蛋白酶的抑制活性和/或氧化反应活性的捕捉活性。

  公开号：

  US20090018120A1

文献信息

• Novel derivatives of 2-hydroxytetrahydrofuran and their use as medicaments
  申请人：Auvin Serge

  公开号：US20050222045A1

  公开（公告）日：2005-10-06

  The invention relates to derivatives of 2-hydroxytetrahydrofuran corresponding to general formula (I) in which A represents the radical, in which R 1 , R 2 , R 4 , R 5 and R 6 represent (in particular), independently, H, a halogen atom, OH, alkyl or alkoxy, R 3 represents H, alkyl or —COR 10 , R 10 representing H, alkyl or alkoxy, and W represents a bond, —CH 2 —CH 2 —, —CH═CH—, —O—, —S— or —NR 11 — in which R 11 represents H or alkyl; X represents —CO—, —Y—CO—, —O—Y—CO— or —NR 12 —Y—CO—, Y represents an alkylene or haloalkylene alkyl, R 12 represents H, alkyl or —COR 13 , R 13 represents H, alkyl, haloalkyl or alkoxy, AA represents, each time that it occurs, a natural or non-natural amino acid; n represents 2 or 3; and finally R represents H, alkyl or —CO—R 19 , R 19 representing alkyl. These compounds have a calpain inhibiting activity and/or an activity which traps the reactive oxygen species and can be used for preparing a medicament intended to treat the inflammatory and immunological diseases, cardio-vascular and cerebro-vascular diseases, disorders of the central or peripheral nervous system, cachexia, osteoporosis, muscular dystrophy, proliferative diseases, cataract, rejection reactions following organ transplants and autoimmune and viral diseases.

  该发明涉及与通式（I）相对应的2-羟基四氢呋喃衍生物，其中A代表基团，其中R1、R2、R4、R5和R6代表（特别是），独立地为H、卤素原子、OH、烷基或烷氧基，R3代表H、烷基或—COR10，R10代表H、烷基或烷氧基，W代表键，—CH2—CH2—、—CH═CH—、—O—、—S—或—NR11—，其中R11代表H或烷基；X代表—CO—、—Y—CO—、—O—Y—CO—或—NR12—Y—CO—，Y代表烷基或卤代烷基，R12代表H、烷基或—COR13，R13代表H、烷基、卤代烷基或烷氧基，AA代表，每次出现时，一个天然或非天然氨基酸；n代表2或3；最后R代表H、烷基或—CO—R19，R19代表烷基。这些化合物具有抑制钙蛋白酶活性和/或捕获活性氧物质的活性，可用于制备用于治疗炎症和免疫性疾病、心血管和脑血管疾病、中枢或外周神经系统疾病、虚弱、骨质疏松症、肌肉萎缩症、增殖性疾病、白内障、器官移植后的排斥反应以及自身免疫和病毒性疾病的药物。
• COMPOSITION CONTAINING AMIDINE DERIVATIVES OR CARBOXAMIDE DERIVATIVES AND STEROIDS, AS A MEDICAMENT
  申请人：Pignol Bernadette

  公开号：US20090149430A1

  公开（公告）日：2009-06-11

  The present invention relates to a composition containing at least one amidine derivative or carboxamide derivative of general formula (I) or (A) in combination with at least one compound chosen from steroids, corticoids or corticosteroids, wherein said composition is suitable for the preparation of a medicament.

  本发明涉及一种含有至少一种氨基甲酸酰胺衍生物或一般式(I)或(A)的羧酰胺衍生物的组合物，与至少一种来自类固醇、皮质类固醇或皮质类固醇的化合物结合在一起，所述组合物适用于制备药物。
• Lactol derivatives, their production and use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05496834A1

  公开（公告）日：1996-03-05

  The present invention provides novel compound of the formulas (Ia) or (I): ##STR1## wherein Q is one or two amino acid residues which may be substituted; R.sup.3 is a carboxyl group which may be esterified or an acyl group; A is an alkylene group; B is hydrogen or an alkyl group which may be substituted or an acyl group; or a salt thereof; ##STR2## wherein R.sup.1 and R.sup.2 may be the same or different and each is hydrogen or a hydrocarbon residue which may be substituted; R.sup.3, A and B have the same definitions as those shown above; m and n each is 0 or 1; provided that where both m and n are both equal to 0, R.sup.3 is a carboxyl group which may be esterified or an acyl group having not less than 7 carbon atoms; or a salt thereof. The compound (Ia) or (I) shows cathepsin L inhibitory and bone resorption inhibitory activities and are useful as a prophylactic/therapeutic agent for osteoporosis.

  本发明提供了式(Ia)或(I)的新化合物：##STR1## 其中Q是一个或两个氨基酸残基，可以被取代；R.sup.3是一个羧基，可以被酯化或酰基化；A是一个烷基；B是氢或一个可以被取代的烷基或酰基；或其盐；##STR2## 其中R.sup.1和R.sup.2可以相同也可以不同，每个都是氢或可以被取代的碳氢残基；R.sup.3，A和B具有与上述所示相同的定义；m和n各自为0或1；但是，当m和n都等于0时，R.sup.3是一个羧基，可以被酯化或酰基化，具有不少于7个碳原子的酰基；或其盐。化合物(Ia)或(I)显示出抑制半胱氨酸蛋白酶L和抑制骨吸收的活性，并且可用作预防/治疗骨质疏松症的药物。
• Novel 2-hydroxytetrahydrofurane derivatives and use thereof as medicaments
  申请人：Auvin Serge

  公开号：US20060166893A1

  公开（公告）日：2006-07-27

  A hydroxytetrahydrofuran of formula wherein A is with the substituents as defined in the specification, having a calpain inhibiting activity and/or an activity which traps the reactive oxygen species useful for treating inflammatory and immunological diseases, cardio-vascular and cerebro-vascular diseases, disorders of the central or peripheral nervous system, osteoporosis, muscular dystrophy, proliferative diseases, cataract, rejection reactions following organ transplants and autoimmune and viral diseases.

  一种羟基四氢呋喃，其化学式为其中A为，在规范中定义的取代基，具有钙蛋白酶抑制活性和/或捕获反应性氧化物种的活性，可用于治疗炎症和免疫性疾病、心血管和脑血管疾病、中枢或外周神经系统疾病、骨质疏松症、肌肉萎缩症、增生性疾病、白内障、器官移植后的排斥反应以及自身免疫和病毒性疾病。
• Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments
  申请人：Societe de Conseils de Recherches Et d'Applications Scientifiques (S.C.R.A.S.)

  公开号：US07384933B2

  公开（公告）日：2008-06-10

  A hydroxytetrahydrofuran of formula wherein A is with the substituents as defined in the specification, having a calpain inhibiting activity and/or an activity which traps the reactive oxygen species useful for treating inflammatory and immunological diseases, cardio-vascular and cerebro-vascular diseases, disorders of the central or peripheral nervous system, osteoporosis, muscular dystrophy, proliferative diseases, cataract, rejection reactions following organ transplants and autoimmune and viral diseases.

  一种羟基四氢呋喃，其化学式为其中A为，其取代基如规范中所定义，具有钙蛋白酶抑制活性和/或捕获反应性氧化物种的活性，用于治疗炎症和免疫性疾病、心血管和脑血管疾病、中枢或外周神经系统疾病、骨质疏松症、肌肉萎缩症、增生性疾病、白内障、器官移植后的排斥反应以及自身免疫和病毒性疾病。